Gadolinium polytungstate nanoclusters: a new theranostic with ultrasmall size and versatile properties for dual-modal MR/CT imaging and photothermal therapy/radiotherapy of cancer
Open accessThe DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
The development of a new generation of nanoscaled theranostics with simple compositions and versatile properties to realize enhanced diagnoses and treatment outcomes and to avoid side effects is highly desirable but remains a great challenge. Here we report a new ultrasmall theranostic based on bovine serum albumin-coated GdW10O36 nanoclusters (GdW10 NCs) as multifunctional theranostics for multifunctional bio-imaging, highly effective in vitro photothermal ablation of cancer cells and in vivo radiotherapy of tumors. The as-synthesized GdW10 NCs afford significantly enhanced computed tomography/magnetic resonance imaging signals and remarkable photothermal therapy (PTT)/radiotherapy therapy (RT) therapeutic effects for tumor treatment. Moreover, toxicity studies confirmed their low toxicity and efficient renal clearance, suggesting their potential for practical applications. These results indicated that the as-prepared GdW10 nanoclusters are promising as multifunctional nanotheranostics for multimodal imaging-guided PTT/RT of tumors. These results also encourage the further exploration of other polyoxometalate-based multifunctional nanotheranostics for cancer diagnoses and therapy. Nanostructures that can diagnose tumours and treat them with laser light and radiotherapy have been developed by researchers in China. ‘Theranostic’ nanoparticles that combine bioimaging with targeted action against cancer cells are often too large to pass safely through the kidney, leading to cytotoxicity issues. To overcome such problems, Zhanjun Gu from the Chinese Academy of Sciences and co-workers synthesized polytungstates nanoclusters containing rare-earth gadolinium ions and coated them with a biocompatible protein film. These water-soluble, sub-5-nanometre particles enhanced magnetic resonance and computed tomography imaging thanks to the gadolinium components. In vivo tests in mice revealed that the nanoclusters localized in tumour microstructures where they could be excited by laser or X-ray beams to damage and repress tumour formation. Afterwards, the nanoparticles were cleared through the kidney harmlessly. In this work, a new theranostics based on GdW10@BSA NCs with ultrasmall size, but versatile properties, were fabricated, which possesses not only significant CT/ MR imaging signal enhancement but also remarkable photothermal therapy (PTT)/radiotherapy (RT) therapeutic effects for tumor. Therefore, our work may open an avenue in developing other POM-based multifunctional nanomedicines with better therapeutic outcome and fewer side effects.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Design considerations for tumour-targeted nanoparticles
Choi, H. S., Liu, W., Liu, F., Nasr, K., Misra, P., Bawendi, M. G., & Frangioni, J. V. (2010) · Nature Nanotechnology · doi:10.1038/nnano.2009.314 · Cited by 754
Nanotheranostics and image-guided drug delivery: current concepts and future directions
Lammers, T., Kiessling, F., Hennink, W. E., & Storm, G. (2010) · Molecular Pharmaceutics · doi:10.1021/mp100228v · Cited by 397
Cited by
Emerging Nanotechnology and Advanced Materials for Cancer Radiation Therapy
Song, G., Cheng, L., Chao, Y., Yang, K., & Liu, Z. (2017) · Advanced Materials · doi:10.1002/adma.201700996 · Cited by 771
Recent advances in functional nanomaterials for light–triggered cancer therapy
Gai, S., Yang, G., Yang, P., He, F., Lin, J., Jin, D., & Xing, B. (2018) · Nano Today · doi:10.1016/j.nantod.2018.02.010 · Cited by 568
Dai, C., Chen, Y., Jing, X., Xiang, L., Yang, D., Lin, H., Liu, Z., Han, X., & Wu, R. (2017) · ACS Nano · doi:10.1021/acsnano.7b07241 · Cited by 520
Inorganic nanomaterials with rapid clearance for biomedical applications
Wang, X., Zhong, X., Li, J., Liu, Z., & Cheng, L. (2021) · Chemical Society Reviews · doi:10.1039/d0cs00461h · Cited by 509
Application of Radiosensitizers in Cancer Radiotherapy
Gong, L., Zhang, Y., Liu, C., Zhang, M., & Han, S. (2021) · International Journal of Nanomedicine · doi:10.2147/ijn.s290438 · Cited by 479
Emerging Strategies of Nanomaterial‐Mediated Tumor Radiosensitization
Xie, J., Gong, L., Zhu, S., Yong, Y., Gu, Z., & Zhao, Y. (2019) · Advanced Materials · doi:10.1002/adma.201802244 · Cited by 415
Self-citationGuo, Z., Zhu, S., Yong, Y., Zhang, X., Dong, X., Du, J., Xie, J., Wang, Q., Gu, Z., & Zhao, Y. (2017) · Advanced Materials · doi:10.1002/adma.201704136 · Cited by 327
Self-citationZhou, R., Wang, H., Yang, Y., Zhang, C., Dong, X., Du, J., Yan, L., Zhang, G., Gu, Z., & Zhao, Y. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2018.10.016 · Cited by 178
Self-citationBilynsky, C., Millot, N., & Papa, A. (2022) · Bioengineering & Translational Medicine · doi:10.1002/btm2.10256 · Cited by 52
“They are highly effective in vitro for photothermal ablation of cancer cells and in vivo for radiotherapy of tumors.(65) Lux et al.”
BackgroundEvaluation of efficacy of tumor-specific nanoliposomal radiosensitizer in radiotherapy
Karabuga, M., Erdogan, S., Filikci, K., Hazıroglu, R., Tuncel, M., & Cengiz, M. (2023) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2023.104586 · Cited by 6
Metadata
- Authors
- Yong, Y., Zhou, L., Zhang, S., Yan, L., Gu, Z., Zhang, G., & Zhao, Y.
- Venue
- NPG Asia Materials
- Published
- 2016-05
- Volume
- 8
- Issue
- 5
- Pages
- e273-e273
- ISSN
- 1884-4049 (ISSN-L)
- 1884-4057
- OpenAlex
- W2394578779
- Cited by
- 89
- References
- 2
- FWCI
- 6.54
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.